Improving Diabetes Medication, Adherence and Outcomes
Improving Diabetes Medication, Adherence and Outcomes
批准号:
6897922
负责人:
ELIZABETH A. WALKER
金额:
$65.4万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Metabolic control of type 2 diabetes and prevention of its complications are related to management of blood glucose and other factors. Medication and lifestyle modifications are integral to most self-management plans; however, adherence remains a great challenge. Many patients have abnormal HbA1c, blood pressure and lipid values, and are at greater risk for complications. This proposal is to evaluate the effectiveness and costs of a tailored, telephone intervention to promote adherence in middle-aged and older adults with type 2 diabetes who are members of a union/employer-sponsored health benefit plan. The target population includes English-and Spanish-speaking individuals from the health plan database. Specific aims of the proposal are to test the hypotheses that 1) a tailored telephone intervention will significantly improve medication adherence compared to a standard care intervention; and 2) a tailored telephone intervention will significantly improve metabolic control measured by HbA1c compared to the standard care intervention. Aim 2a is to explore ways to link behavior change for medication adherence with lifestyle modification for diet and physical activity. Aim 3 is to conduct cost evaluations for the telephone intervention vs. standard care. The study design is a randomized, controlled intervention trial with masking; the individual is the unit of sampling, assignment and analysis. After eligibility is assessed and consent is obtained by telephone, patients will be randomized by gender and language preference (English or Spanish) to either the telephone intervention or standard care. Study outcomes will be medication adherence as measured from pharmacy records and metabolic control (HbA1c). A total of 556 patients with type 2 diabetes will be randomized, which will provide 80 percent power to detect a statistically significant difference in HbA1c of at least 0.3 percent, and over 95 percent power to detect a difference in filled prescriptions. Telephone surveys will provide data on self-care behaviors including diet and exercise, risk perceptions, and depressive symptoms. Cost data will be collected using standardized methods. Study results will inform implementation of practical, nurse-managed interventions to improve medication adherence and metabolic control in diverse, middle-aged and older, type 2 diabetes patients, while linking changes in medication adherence to lifestyle modification for diet and physical activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translating the Diabetes Prevention Program to Engage Men in Disadvantaged Areas
-
批准号:8755373
-
项目类别:
-
资助金额:$21.2万
-
财政年份:2014
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Prevention and Control Core
-
批准号:7925430
-
项目类别:
-
资助金额:$44.19万
-
财政年份:2010
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:8134085
-
项目类别:
-
资助金额:$14.11万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:7408088
-
项目类别:
-
资助金额:$44.72万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:7245289
-
项目类别:
-
资助金额:$49.39万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:7668867
-
项目类别:
-
资助金额:$12.73万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:7802931
-
项目类别:
-
资助金额:$49.35万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:8069142
-
项目类别:
-
资助金额:$43.76万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Bronx A1c: Bring it Down for Health
-
批准号:7617249
-
项目类别:
-
资助金额:$60.85万
-
财政年份:2007
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:7186194
-
项目类别:
-
资助金额:$3.31万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:7071213
-
项目类别:
-
资助金额:$67.33万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:7231944
-
项目类别:
-
资助金额:$47.31万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:6757842
-
项目类别:
-
资助金额:$63.35万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:7155825
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
Improving Diabetes Medication, Adherence and Outcomes
-
批准号:6617212
-
项目类别:
-
资助金额:$59.8万
-
财政年份:2003
-
负责人:ELIZABETH A. WALKER
-
依托单位:
EVALUATING ALTERNATE RETINOPATHY SCREENING INTERVENTIONS
-
批准号:6194634
-
项目类别:
-
资助金额:$62.82万
-
财政年份:2000
-
负责人:ELIZABETH A. WALKER
-
依托单位:
EVALUATING ALTERNATE RETINOPATHY SCREENING INTERVENTIONS
-
批准号:6384924
-
项目类别:
-
资助金额:$63.05万
-
财政年份:2000
-
负责人:ELIZABETH A. WALKER
-
依托单位:
EVALUATING ALTERNATE RETINOPATHY SCREENING INTERVENTIONS
-
批准号:6799991
-
项目类别:
-
资助金额:$74.34万
-
财政年份:2000
-
负责人:ELIZABETH A. WALKER
-
依托单位:
EVALUATING ALTERNATE RETINOPATHY SCREENING INTERVENTIONS
-
批准号:6665049
-
项目类别:
-
资助金额:$72.32万
-
财政年份:2000
-
负责人:ELIZABETH A. WALKER
-
依托单位:
EVALUATING ALTERNATE RETINOPATHY SCREENING INTERVENTIONS
-
批准号:6735916
-
项目类别:
-
资助金额:$2.46万
-
财政年份:2000
-
负责人:ELIZABETH A. WALKER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
基于Notch-1介导miR-200家族调控上皮间质转化对绒癌耐药机制的研究
-
批准号:81972428
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:安瑞芳
-
依托单位:
地塞米松诱导的人卵巢癌对化疗药物耐受及其机制的研究
-
批准号:81172471
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2011
-
负责人:陈玉霞
-
依托单位:
维生素B3促进化疗导致粒细胞减少症的中性粒细胞生成功能及作用机制研究
-
批准号:81060045
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:蓝丹
-
依托单位:
番荔枝内酯抗肿瘤作用及调节肿瘤耐药分子调控网络研究
-
批准号:30973854
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:欧阳学农
-
依托单位:
应用蛋白敲除技术降解ErbB家族的抗乳腺癌作用及其机制研究
-
批准号:30901754
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:李慧
-
依托单位:
卵巢癌肿瘤干细胞特异性microRNA分子靶点调控的研究
-
批准号:30873011
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2008
-
负责人:沈铿
-
依托单位:
巨噬细胞诱导的大肠癌靶向治疗实验研究
-
批准号:30471998
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2004
-
负责人:张继民
-
依托单位: